This chemical is widely used in the development of drug delivery systems, particularly in the formulation of liposomes and nanoparticles. Its amphiphilic nature allows it to stabilize lipid bilayers, enhancing the encapsulation and controlled release of therapeutic agents. As a PEGylated phospholipid featuring a terminal amino group on the polyethylene glycol (PEG-2000) chain, it enables the formation of stealth liposomes that evade the immune system and prolong circulation time of drugs in the bloodstream, reducing off-target effects. It is commonly employed in targeted cancer therapies, where the amino group facilitates covalent conjugation with ligands, antibodies, or other moieties to improve delivery to specific tissues or cells, thereby increasing efficacy. Its application also extends to diagnostic imaging, where it aids in the development of contrast agents for improved visualization of biological structures.